MEDCL
Sign in
MedinCell S.A.
Save
468.37M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
MedinCell S. A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients.
Similar securities
Based on sector and market capitalization
Report issue